comparemela.com

Vanessa Cavallera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China

AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significance as set out apriori through hierarchical.

South koreaJapan generalTheo vosEric hughesTarun duaBochen caoChiara serviliChristopherjl murrayEmma nicholsKatrin seeherJaimied steinmetzVanessa cavalleraShengyuan yuValeryl feiginTeva pharmaceutical industries ltdTeva pharmaceuticals

vimarsana © 2020. All Rights Reserved.